Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker for Insulin Resistance in Polycystic Ovary Syndrome
調査の概要
研究の種類
入学 (推定)
連絡先と場所
研究場所
-
-
-
Guangzhou、中国
- Guangdong Women and Children Hospital
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
This study included PCOS patients diagnosed according to the 2003 Rotterdam criteria (at least 2 of: oligo/anovulation, clinical/biochemical hyperandrogenism, or polycystic ovaries on ultrasound). Patients were divided into two groups:
PCOS-IR group: met PCOS criteria plus at least one of: HOMA-IR ≥ 2.5, fasting insulin ≥ 15 μIU/mL, or diagnosed IGT/T2DM.
PCOS-non-IR group: met PCOS criteria with HOMA-IR < 2.5 and no glucose metabolism abnormalities.
Exclusion criteria: other endocrine disorders, medication use, severe systemic diseases, pregnancy/lactation, or poor sample quality.
説明
I. Diagnostic Criteria
The 2003 Rotterdam diagnostic criteria for PCOS jointly established by the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM):
Clinical and/or biochemical signs of hyperandrogenism; Oligo-ovulation or anovulation; Ultrasound findings: ovarian volume ≥ 10 mL, and/or > 12 follicles with a diameter of 2-9 mm in a single section.
A diagnosis of PCOS can be established when at least two of the following three criteria are met: ovarian dysfunction, hyperandrogenism, and polycystic ovarian morphology on ultrasound.
II. Inclusion and Exclusion Criteria
PCOS with Insulin Resistance (PCOS-IR)
Inclusion Criteria:
Meets the 2003 Rotterdam diagnostic criteria for PCOS (at least 2 of the following 3 items):
① Oligo-ovulation or anovulation;
② Clinical or biochemical signs of hyperandrogenism;
③ Polycystic ovaries on ultrasound (unilateral or ovarian volume ≥ 10 mL).
Insulin resistance (IR), meeting at least 1 of the following 3 criteria:
① HOMA-IR ≥ 2.5;
② Fasting insulin ≥ 15 μIU/mL;
③ Diagnosed impaired glucose tolerance (IGT) or type 2 diabetes mellitus (T2DM).
Exclusion Criteria:
Other endocrine disorders; Medication effects; Severe systemic diseases; Special physiological conditions (e.g., pregnancy, lactation); Poor sample quality.
- PCOS without Insulin Resistance (PCOS-non-IR)
Inclusion Criteria:
Meets the PCOS diagnostic criteria (as above), with HOMA-IR < 2.5 and no glucose metabolism abnormalities.
Exclusion Criteria: Same as above.
研究計画
研究はどのように設計されていますか?
デザインの詳細
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
adverse pregnancy outcomes and long-term complications such as type 2 diabetes mellitus
時間枠:1year
|
1year
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。